Back to Longevity
Longevity

ApoBEvidence & Dosage

A better cardiovascular risk metric than LDL-C — modern lipidology.

Evidence at a glance

Total studies
1,000
With abstract
42
Meta / Systematic / RCT
0
Highly cited
3
Publication years
1974–2026

ApoB in the context of Longevity

This topic is part of our "Longevity" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Longevity

Top studies on ApoB

Ranked by influential-citation count and publication year.

  1. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

    Science (New York, N.Y.)1992200 influential citations

    Apolipoprotein E (apoE) is a ligand for receptors that clear remnants of chylomicrons and very low density lipoproteins. Lack of apoE is, therefore, expected to cause accumulation in plasma of cholesterol-rich remnants whose prolonged…

  2. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

    Lancet (London, England)2001n=98,722200 influential citations

    <h4>Background</h4>Apolipoprotein B (apoB) and apolipoprotein A-I (apoA-I) are thought to be better predictors of acute myocardial infarction than total cholesterol and LDL-cholesterol. We investigated whether apoB and apoA-I are…

  3. Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.

    JAMA2017n=46,89149 influential citations

    <h4>Importance</h4>The activity of lipoprotein lipase (LPL) is the rate-determining step in clearing triglyceride-rich lipoproteins from the circulation. Mutations that damage the LPL gene (LPL) lead to lifelong deficiency in enzymatic…

  4. THR-&#x3b2; Agonists vs Incretin Therapies for Noncirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Biopsy-Anchored Systematic Review With Grading of Recommendations Assessment, Development and Evaluation (GRADE) Certainty.

    Cureus2026n=3,796D

    Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease now targeted by new pharmacotherapies, including the thyroid hormone receptor beta (THR-&#x3b2;) agonist resmetirom, glucagon-like peptide-1 (GLP-1)…

  5. Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins.

    Cardiovascular diabetology2026n=10,497D

    Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality in individuals with diabetes, partly driven by dyslipidemia. While low-density lipoprotein cholesterol (LDL-C) reduction is the primary…

  6. Subtype-specific associations between serum lipid profiles and disease severity in patients with amyotrophic lateral sclerosis.

    Biomedical reports2026n=158

    Amyotrophic lateral sclerosis (ALS) is a heterogeneous neurodegenerative disorder. Notably, the differences in lipid metabolism between bulbar- and limb-onset subtypes of ALS remain unclear, particularly in non-Western populations. The…

  7. Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies: A Phase 3 Randomized Clinical Trial.

    Journal of the American College of Cardiology2026n=101

    <h4>Background</h4>Many adults fail to achieve guideline-directed low-density lipoprotein cholesterol (LDL-C) goals on statin monotherapy, requiring additional nonstatin lipid-lowering medication. Enlicitide, an oral proprotein convertase…

  8. Effect of angiopoietin-like protein 3 inhibitors on lipid profile and other biomarkers: a meta-analysis of randomized controlled trials.

    European journal of preventive cardiology2026n=1,254

    <h4>Aims</h4>Inhibition of angiopoietin-like protein 3 (ANGPTL3) has been proposed as a promising approach to reduce residual cardiovascular risk. We conducted a meta-analysis of randomized controlled trials (RCTs) to provide a…

  9. [Combined Analysis of Dyslipidemia and Tumor Markers for the Diagnosis of Gastric Cancer].

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026n=100

    <h4>Objective</h4>To investigate changes in serum lipid profile parameters combined with tumor markers in gastric cancer (GC) patients and their value in GC screening.<h4>Methods</h4>A total of 100 patients diagnosed with GC at Renji…

  10. Persistent sex differences in cardiovascular disease risk factors: a longitudinal cohort study in youth with type 1 diabetes.

    American journal of preventive medicine2026

    <h4>Introduction</h4>Women with type 1 diabetes (T1D) experience a greater diabetes-related increase in cardiovascular disease (CVD) and mortality risk than men. This study aimed to examine early sex-related differences in CVD risk factors…

Related articles

More topics in Longevity

Zone 2 Training

Low-intensity cardio — mitochondrial biogenesis, a longevity foundation.

Rapamycin

mTOR inhibition, longevity studies, off‑label dosing, and safety.

AMPK Activators

Berberine, alpha‑lipoic acid, energetic stress, and glucose modulation.

Autophagy

Cellular self-clearance — fasting, exercise, spermidine as triggers.

Berberin

Glucose, lipids, AMPK and GI tolerability data

Biological Age

GrimAge, PhenoAge, DunedinPACE — what epigenetic clocks measure.

Caloric Restriction

CR mimetics, lifespan research, and NHP studies.

Cancer Screening

Recommendations, overdiagnosis, Galleri tests, whole-body MRI (a critical look).

Cellular Senescence

"Zombie cells," SASP, senolytic approaches.

Collagen

Skin, joints, tendons — evidence favors hydrolysate plus vitamin C.

Dementia Prevention

Lifestyle factors: exercise, sleep, hearing health, vascular health.

DEXA Bone Density

DEXA scan for bone + body composition — the trend matters more than a single value.

Epigenetic Clocks

Horvath, GrimAge, PhenoAge — what they measure and what they don't.

Epigenetics

DNA methylation, histone modifications, environmental influences on gene expression.

Exosomes

Cell-to-cell communication, regenerative applications, an early research field.

Genetic Tests

Variants, pharmacogenomics, limitations — methylation, MTHFR myths.

Glucosamine

Joints, UK Biobank mortality study, sulfate vs HCl forms.

Glycine

Methylation, collagen synthesis, lifespan signals in animal models.

Grip Strength

A strong mortality predictor — easy to measure, trainable.

Hallmarks of Aging

Genomic instability, telomere shortening, epigenetic alterations, and more.

Related topics from other worlds